Many pan-cancer tumor targets, including human epidermal growth factor receptor 2 (HER2), mucin 1 (MUC1), and EGFR, are also expressed at high levels in UCs and may serve as therapeutic targets [50, 51]. The gene discussed is ERBB2; the disease is cancer.